Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead Sciences • El Segundo, CA

10d • $205,615 - $292,710 • Hybrid

About The Position

Kite is seeking a Director, Global Value & Access Strategy (GVAS) for its cell-therapy autoimmune portfolio. Reporting to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline, this role is office-based/hybrid, with three days onsite in El Segundo, Thousand Oaks, or Foster City, California.

The Director will serve as a critical Global Value & Access partner for Kite’s growing autoimmune cell-therapy portfolio, leading global market access strategies for early- and late-stage development programs and preparing for future launches across autoimmune diseases. The role partners with Global Clinical Development, Medical Affairs, HEOR/RWE, Commercial, Regulatory Affairs, and regional Access teams to incorporate payer perspectives into development decisions and launch planning. It also shapes evidence-generation strategies to support differentiated value propositions, reimbursement, and patient access across major global markets.

The role leads cross-functional market access work across the product lifecycle, from early development through launch and lifecycle management. It assesses payer, HTA, and health-system requirements; advises development teams on evidence needs; and translates market insights into recommendations for development, pricing, reimbursement, and commercialization. The Director also provides strategic leadership on US access dynamics, including formulary and utilization management and rebate contracting, and advises governance teams on access implications and the likelihood of favorable pricing, reimbursement, and patient access outcomes.

As a people leader, the Director is expected to foster inclusion, develop talent through coaching and development opportunities, and empower teams by aligning priorities, removing barriers, and encouraging accountability.

Requirements

• At least 8 years of experience with a PhD or PharmD; or at least 10 years with an MS/MA, MBA, PharmD, PhD, or equivalent advanced degree; or at least 12 years with a BS/BA.
• Strong understanding of global payer, pricing, reimbursement, and HTA landscapes.
• Experience supporting market access, pricing, reimbursement, HEOR, commercial strategy, or related functions within the pharmaceutical or biotechnology industry.
• Experience supporting early- and/or late-stage development programs and translating payer insights into development decisions.
• Demonstrated experience incorporating payer, HTA, and health-system requirements into clinical development and evidence-generation strategies.
• Experience partnering with HEOR, RWE, Medical Affairs, Clinical Development, and Commercial functions to develop value evidence strategies.
• Understanding of value frameworks, reimbursement pathways, and evidence requirements across major global markets.
• Demonstrated ability to influence cross-functional teams in a matrix environment.
• Strong strategic thinking, analytical, and problem-solving skills.
• Excellent communication skills and experience presenting to senior leadership.
• Ability to collaborate across functions, regions, cultures, and time zones.
• Ability to thrive in a fast-paced environment characterized by innovation and portfolio growth.

Nice To Haves

• At least 3 years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, commercial strategy, or related functions.
• Deep understanding of autoimmune disease treatment paradigms, competitive dynamics, and unmet patient needs.
• Experience in advanced therapies, including cell therapy and/or gene therapy, is strongly preferred.
• Experience supporting launch-readiness activities, global launch planning, and lifecycle management.

Responsibilities

• Serve as the Global Market Access representative for assigned autoimmune programs and contribute to cross-functional discussions.
• Lead and partner with Global and Regional Value & Access, HEOR/RWE, and Commercial functions to integrate access input into portfolio strategy.
• Lead global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.
• Ensure payer, HTA, and health-system perspectives are incorporated into development, evidence generation, pricing, and commercialization strategies.
• Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.
• Analyze market access trends, reimbursement requirements, competitive dynamics, and health-system considerations across major markets, including the US, EU5, Canada, Australia, and Japan.
• Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence-generation plans.
• Advise development teams on evidence requirements for future reimbursement, pricing, and formulary access decisions.
• Ensure access considerations are reflected in development milestones and governance decisions.
• Partner with Clinical, HEOR, RWE, and Medical Affairs to develop and execute early payer engagement and HTA scientific-advice strategies across autoimmune indications.
• Provide strategic leadership on US market access dynamics, including payer formulary management, utilization management, and rebate contracting strategies.
• Assess payer, HTA, and health-system evidence requirements across key global markets and translate findings into recommendations for clinical development programs.
• Assess access implications of development opportunities across autoimmune indications and advise governance teams on prospects for favorable pricing, reimbursement, and patient access outcomes.
• Partner with HEOR, RWE, Medical Affairs, and Commercial teams to develop value propositions and evidence packages.
• Advise on development of economic models, burden-of-illness studies, indirect treatment comparisons, and other payer-focused evidence.
• Lead market access within cross-functional teams and support alignment across Development, Medical Affairs, Commercial, Regulatory Affairs, Pricing, and HEOR.
• Influence strategic decisions through assessment of payer expectations, reimbursement risks, and value opportunities.
• Model inclusive leadership and foster an environment where diversity and belonging support innovation and performance.
• Coach and develop employees, helping them grow and achieve career goals.
• Align teams to organizational priorities, remove barriers, and encourage accountability.

Benefits

• Discretionary annual bonus may be available.
• Discretionary stock-based long-term incentives may be available; eligibility may vary by role.
• Paid time off.
• Company-sponsored medical insurance.
• Company-sponsored dental insurance.
• Company-sponsored vision insurance.
• Company-sponsored life insurance.

What This Job Offers

• Job Type: Full-time
• Career Level: Director